Quantcast
Last updated on April 16, 2014 at 14:42 EDT

Latest Galena Biopharma Inc. Stories

2014-04-07 16:25:49

BERKELEY, Calif., April 7, 2014 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP reminds investors of the May 5, 2014 deadline to file for lead plaintiff in a securities fraud case against Galena Biopharma, Inc. (NASDAQ: GALE) ("Galena" or "the Company"). The Class Period has been extended to cover investors who bought stock between May 9, 2013 and March 17, 2014 (the "Class Period"). Investors who purchased Galena securities during the Class Period may contact Hagens Berman Partner...

2014-03-18 12:28:55

BOSTON, March 18, 2014 /PRNewswire/ -- Shares in Galena Biopharma, Inc. ("Galena" or the "Company") (NASDAQ: GALE) have plunged on news of alleged improper and misleading marketing and advertising. Today, Galena acknowledged that the United States Securities and Exchange Commission has opened an investigation into whether Galena misled its investors. Since February 12, 2014, when TheStreet.com published a story claiming that Galena was engaged in a misleading brand awareness...

2014-03-12 16:26:33

SAN DIEGO and LAKE OSWEGO, Ore., March 12, 2014 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Galena Biopharma, Inc. (NASDAQ: GALE) has filed a federal securities fraud class action complaint in the U.S. District Court for the District of Oregon. The complaint alleges that the company and certain of its officers and directors violated the Securities and Exchange Act of 1934 between November 6, 2013 and February 14, 2014 (the "Class...

2014-03-06 16:27:07

NEW YORK, March 6, 2014 /PRNewswire/ -- Bernstein Liebhard LLP today announced that a class action has been commenced in the United States District Court for the District of Oregon on behalf of purchasers (the "Class") of common stock of Galena Biopharma, Inc. ("Galena" or the "Company") (NASDAQ: GALE) during the period of November 6, 2013 and February 14, 2014 (the "Class Period"). http://photos.prnewswire.com/prnvar/20120202/MM47134LOGO The complaint charges Galena and certain of...

2013-12-04 08:30:12

NEW YORK, December 4, 2013 /PRNewswire/ -- Market Buzz Report, provides daily stock updates, highlights notable stock news for Herbalife Ltd.(NYSE:HLF), 3D Systems Corporation(NYSE:DDD), Federal National Mortgage Association(OTCBB:FNMA), Galena Biopharma Inc(NASDAQ:GALE), Oncomed Pharmaceuticals Inc(NASDAQ:OMED). Herbalife Ltd.(NYSE:HLF) bulls get (more) good news this afternoon as a Belgian appeals court has apparently overturned a previous ruling that found the...

2013-10-01 08:27:18

NEW YORK, October 1, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Investors' Reports announced new research reports highlighting Cubist Pharmaceuticals Inc. (NASDAQ: CBST), Halozyme Therapeutics, Inc. (NASDAQ: HALO), Taro Pharmaceutical Industries Ltd. (NYSE: TARO), Galena Biopharma, Inc. (NASDAQ: GALE) and Sequenom Inc. (NASDAQ: SQNM). Today's readers may access these reports free of charge - including full...

2013-08-02 12:23:24

LONDON, August 2, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. On Thursday, August 1, 2013, shares in biotechnology companies ended mostly higher, tracking the broader market which also finished high on the back of positive US economic statistics. The major movers in the industry included MannKind Corporation (NASDAQ: MNKD), Galena Biopharma Inc. (NASDAQ: GALE), Ariad Pharmaceuticals Inc. (NASDAQ: ARIA), and Novavax...

2013-04-23 08:34:18

LONDON, April 23, 2013 /PRNewswire/ -- Following the expiration of patents on several blockbuster drugs, big pharma companies have been looking to boost their product pipeline. While in-house research and development will be crucial to boost product pipeline, major pharma companies may also benefit by collaborating with emerging biotechnology companies that have developed or are developing potential blockbuster drugs. Biotechnology stocks ended mostly lower on Monday even as...

2013-03-12 08:28:42

NeuVax(TM) strives to prevent the recurrence of breast cancer and sets a new standard in the global breast cancer vaccines market MOUNTAIN VIEW, Calif., March 12, 2013 /PRNewswire/ -- Based on its recent analysis of the breast cancer vaccines market, Frost & Sullivan recognizes Galena Biopharma, Inc. (NASDAQ: GALE) with the 2013 Global Frost & Sullivan Award for New Product Innovation. The company's revolutionary product, NeuVax(TM), has the potential to address a huge unmet...

2012-06-12 02:26:37

NEW YORK, June 12, 2012 /PRNewswire/ -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, announced today that their June 7th RetailInvestorConferences.com presentation is now available for on-demand viewing. LINK: www.retailinvestorconferences.com > red "register/ watch event now" button Galena Biopharma's presentation will be available 24/7...